Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Age
10–30
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients Who Completed study A1481156 and Are Judged by the Investigator to Derive Clinical Benefit from Continued Treatment with Sildenafil, Prior to Reimbursement and Availability for Subjects in Russian Federation.
Child bearing age women should have appropriate contraception.
Signed informed consent. Patients who have a wish and possibility to follow treatment regimens in terms of the study.
You may not be if
Pregnant and lactating women.
Participation in other studies in the current moment or during study period except of A1481156.
Patients with severe acute or chronic diseases psychiatric disorders or laboratory abnormalities.
Clareo Health | Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With Sildenafil
